How Margin and Mission Work Together at a Multispecialty Group, With Dan Greenleaf of Duly

One third of adults in this country are delaying or forgoing care due to cost. Financial toxicity is clinical toxicity. And yet the standard assumption in healthcare is that affordable prices and financial sustainability are in fundamental tension with each other. Dan Greenleaf's argument — backed by the operating results of Duly, a 1,800-clinician multispecialty group in Chicago — is that they are not.

In this Part 2, Stacey Richter speaks with Dan Greenleaf, CEO of Duly Health and Care, a six-time CEO with three public companies and three PE-backed organizations under his belt, about how Duly generates margin by achieving its mission rather than despite it — and why physician compensation adjusted for inflation is down 36% over 25 years while the competitors he names are sitting on tax-exempt balance sheets of $6 to $24 billion.

WHAT YOU'LL LEARN
✅ How Duly's operational model generates margin: 65% of primary care referrals stay in-network, 76% of specialist-to-ambulatory-surgery-center referrals are captured, and the group's 30 lab sites, 6 ASCs, 16 imaging centers, 11 immediate care centers, and 100 infusion chairs allow it to deliver care at roughly 30% less than institutional competitors — every patient kept in network is a mission win and a margin win simultaneously

✅ Why 600 of Duly's 1,800 physicians are shareholders and 40% of the company is physician-owned — and how aligned financial incentives change the organizational psychology in ways that matter for both culture and operational performance

✅ How five of eleven Duly board seats are held by physicians — and why that governance structure is what actually operationalizes the "dyad leadership" concept that most organizations talk about but few sustain at the board level

✅ How ambient AI scribing reduced physician administrative burden by four and a half hours per week per physician while improving patient experience scores by five percentage points — and what that means for clinician retention and the margin case for mission-aligned technology

✅ Why Dan Greenleaf's framing for capital partners is performance-based rather than mission-based: he competes against organizations with $10 to $24 billion on their balance sheets and his credibility with Ares, his capital partner, comes from a track record of operational performance, not from making the moral case for value-based care

✅ Why the fee-for-service versus value-based care debate misses the point — the real problem is institutional pricing, and every patient Duly keeps out of a hospital system charging 9 to 12 times more is a concrete affordability and quality win regardless of payment model

WHY THIS MATTERS
The mission show is EP489 Part 1. This is Part 2. Dan Greenleaf's central argument is that the successful care models are those that create value inherently — and that reducing friction for patients and reducing friction for clinicians, pursued relentlessly, produces both better outcomes and sustainable margin. The organizational structures that make this possible — physician ownership, physician board seats, aligned incentives, transparent mission metrics — are not incidental to the financial model. They are the financial model.

=== LINKS ===
🔗  Show Notes with all mentioned links:  
https://cc-lnk.com/EP489-Part2

✉️  Enjoy this podcast? Subscribe to the free weekly newsletter:
https://relentlesshealthvalue.com/join-the-relentless-tribe

🫙  Support the podcast with a small donation to the Tip Jar:
https://relentlesshealthvalue.com/join-the-relentless-tribe

📺  Subscribe to our YouTube channel   https://www.youtube.com/@RelentlessHealthValue

🎤  Listen on Apple Podcasts  https://podcasts.apple.com/us/podcast/feed/id892082003?ls=1

🎤  Listen on Spotify  https://open.spotify.com/show/6UjgzI7bScDrWvZEk2f46b

=== CONNECT WITH THE RHV TEAM ===
✭ LinkedIn   https://www.linkedin.com/company/relentless-health-value/
✭ Threads  https://www.threads.net/@relentlesshealthvalue/
✭ Bluesky   https://bsky.app/profile/relentleshealth.bsky.social
✭ X   https://twitter.com/relentleshealth/.

09:56 How does Dan achieve his mission given the realities of margin?

14:49 How Duly Health's approach and incentives differ from other health systems.

16:04 EP466 with Vivian Ho, PhD.

16:28 EP462 with Scott Conard, MD.

16:31 Summer Shorts episode with Stan Schwartz, MD.

17:27 EP460 with Rushika Fernandopulle, MD.

17:29 EP445 with Tom X. Lee, MD.

17:30 EP407 with Vivek Garg, MD, MBA.

18:50 How having physicians on the hospital board greatly improves margin and mission.

20:04 How Dan explains his approach to his capital partners.

22:23 Fee for service vs. institutional care.